|

Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry

RECRUITINGSponsored by University Hospital, Grenoble
Actively Recruiting
SponsorUniversity Hospital, Grenoble
Started2018-02-08
Est. completion2028-02
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03479580

Summary

Long-term prognostic value of macrovascular and microvascular coronary artery stenoses in each type of cardiomyopathy.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Ischemic
* Dilated
* Hypertrophic
* Restrictive cardiomyopathy.

Exclusion Criteria:

* Pregnant women
* Breastfeeding women
* Patients under legal protection

Conditions5

Dilated CardiomyopathiesHeart DiseaseHypertrophicIschemicRestrictive Cardiomyopathy

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.